Acoramidis Mitigates The Rise In Nt-probnp Levels Observed With Placebo In Patients With Variant Transthyretin Amyloid Cardiomyopathy: Results From Attribute-cm

Margot K. Davis; Richard Z. Cheng; Nitasha Sarswat; Jose N. Nativi-Nicolau; Olakunle O. Akinboboye; Brian Drachman; Pablo García‐Pavía; Chris Chen; Suresh R Siddhanti; Jean‐François Tamby; Jonathan C. Fox; Matthew Maurer; Daniel Philip Judge

doi:10.1016/j.cardfail.2025.11.154

Acoramidis Mitigates The Rise In Nt-probnp Levels Observed With Placebo In Patients With Variant Transthyretin Amyloid Cardiomyopathy: Results From Attribute-cm

Journal of Cardiac Failure 2026

View at publisher

Authors: Margot K. Davis, Richard Z. Cheng, Nitasha Sarswat, Jose N. Nativi-Nicolau, Olakunle O. Akinboboye, Brian Drachman, Pablo García‐Pavía, Chris Chen, Suresh R Siddhanti, Jean‐François Tamby, Jonathan C. Fox, Matthew Maurer

+1 more

Daniel Philip Judge

DOI: 10.1016/j.cardfail.2025.11.154

Cited by: 0

Fields of Study & Subjects

Amyloidosis: Diagnosis Treatment Outcomes Alzheimer's disease research and treatments Heart Failure Treatment and Management

Publication details

Journal / source: Journal of Cardiac Failure
Volume: 32
Issue: 1
Pages: 235–235
Publication date: 1 January 2026
Language: EN